Chart calendar Incyte Corporation

44d.wpTxerZZyX3WjpN2WZxt6xg5qmgAGZJ7KGdV5IOtKMQ.jPWHTochux6S4vkxPa8jnU1_0C5sX-pKWy1ljMr_TqqbxskN4gqADu_Hxg~3fd73209943f78e01a88279d6c3d2f92

Upcoming events on Incyte Corporation

2025-12-06

American Society of Hematology Meeting - Publication #71

2025-12-06

American Society of Hematology Meeting - Publication #272

2025-12-06

American Society of Hematology Meeting - Publication #2458

2025-12-06

American Society of Hematology Meeting - Publication #2446

2025-12-06

American Society of Hematology Meeting - Publication #2452

2025-12-06

American Society of Hematology Meeting - Publication #1819

2025-12-06

American Society of Hematology Meeting - Publication #2826

2025-12-06

American Society of Hematology Meeting - Publication #2051

2025-12-07

American Society of Hematology Meeting - Publication #484

2025-12-07

American Society of Hematology Meeting

2025-12-07

American Society of Hematology Meeting - Publication #605

2025-12-07

American Society of Hematology Meeting - Publication #4256

2025-12-07

American Society of Hematology Meeting - Publication #3795

2025-12-07

American Society of Hematology Meeting - Publication #3749

2025-12-07

American Society of Hematology Meeting - Publication #3275

Past events on Incyte Corporation

2025-12-03

Evercore Healthcare Conference

2025-12-02

Citi Global Healthcare Conference

2025-11-18

Jefferies Global Healthcare Conference

2025-11-10

Guggenheim Healthcare Innovation Conference

2025-10-28

Q3 2025 Earnings Call

2025-10-28

Q3 2025 Earnings Release

2025-10-19

European Society of Medical Oncology Congress

2025-10-19

European Society of Medical Oncology Congress - Abstract Number - 1325

2025-10-19

European Society of Medical Oncology Congress - Abstract Number - 916O

2025-10-17

European Society of Medical Oncology Congress - Abstract Number - 1522

2025-09-09

Morgan Stanley Global Healthcare Conference

2025-09-04

Wells Fargo Healthcare Conference

2025-09-03

Cantor Global Healthcare Conference

2025-07-29

Q2 2025 Earnings Call

2025-07-29

Q2 2025 Earnings Release

2025-06-15

European Hematology Association Congress

2025-06-15

European Hematology Association Congress - Abstract No - S212

2025-06-15

European Hematology Association Congress - Abstract No - LB4002

2025-06-14

European Hematology Association Congress - Abstract No - PS2029

2025-06-14

European Hematology Association Congress - Abstract No - PS1598

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
3 395
3 343
1.55%
3 696
3 689
0.17%
4 241
4 197
1.05%

4 976


5 520


6 045

EBITDA
Million USD
Released
Forecast
Spread
598
679
-11.94%
703
724
-2.83%
503
199
152.27%

1 568


1 882


2 020

EBIT
Million USD
Released
Forecast
Spread
579
667
-13.15%
621
720
-13.86%
414
353
17.21%

1 633


1 937


2 229

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
529
554
-4.5%
834
817
2.07%
317
331
-4.48%

1 609


1 688


2 036

Net income
Million USD
Released
Forecast
Spread
341
380
-10.27%
598
596
0.28%
32,6
73,9
-55.87%

1 245


1 342


1 553

EPS
USD
Released
Forecast
Spread
1,52
1,66
-8.5%
2,65
2,63
0.69%
0,15
0,37
-59.34%

6,19


6,72


7,51

Announcement Date07/02/2313/02/2410/02/25-

Quarterly results

Fiscal PeriodSeptember 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million USD
Released
Forecast
Spread
881
925
-4.73%
1 044
1 015
2.86%
1 138
1 077
5.64%
1 179
1 145
2.92%
1 053
998
5.54%
1 216
1 152
5.55%
1 366
1 254
8.91%

1 351


1 245


1 358


1 432


1 495

EBITDA
Million USD
Released
Forecast
Spread
183
213
-14.02%
-357
320
-211.49%
278
231
20.24%



306
279
9.58%
405
338
19.87%
529
400
32.34%

432













EBIT
Million USD
Released
Forecast
Spread
161
199
-18.94%
-379
254
-248.92%
255
207
23.11%
376
353
6.65%
284
219
29.26%
383
337
13.37%
498
400
24.57%

475


474


507


550


582

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
236
198
19.34%
-390
131
-398.63%
157
193
-19.03%
314
334
-5.99%
234
198
18.01%
558
288
93.83%
482
373
29.45%

400


299


421


478


472

Net income
Million USD
Released
Forecast
Spread
170
132
28.79%
-445
184
-341.51%
106
157
-32.31%
201
244
-17.67%
158
144
9.62%
405
217
87.01%
424
260
63.29%

284


302


368


428


420

EPS
USD
Released
Forecast
Spread
0,75
0,59
27.07%
-2,04
0,83
-344.63%
0,54
0,79
-31.26%
1,02
1,24
-17.57%
0,80
0,73
8.85%
2,04
1,14
79.07%
2,11
1,34
57.83%

1,48


1,62


1,83


2,06


2,02

Announcement Date30/04/2430/07/2429/10/2410/02/2529/04/2529/07/2528/10/25-----
2026-01-27

Q4 2025 Earnings Release (Projected)

2026-01-28

Q4 2025 Earnings Release (Projected)

2026-01-29

Q4 2025 Earnings Release (Projected)

2026-01-29

Q1 2026 Earnings Release (Projected)

2026-02-04

Q3 2026 Earnings Release (Projected)

2026-02-04

Q4 2025 Earnings Release (Projected)

2026-02-05

Q4 2025 Earnings Release

2026-02-09

Q2 2026 Earnings Release

2026-02-11

Q4 2025 Earnings Release (Projected)

2026-02-12

Q4 2025 Earnings Release

More events

Past sector events for Incyte Corporation

2025-11-14

Q4 2025 Earnings Release

2025-11-14

Q3 2025 Earnings Release

2025-11-13

Q3 2025 Earnings Release

2025-11-13

Q3 2025 Earnings Release

2025-11-13

Q3 2025 Earnings Release

2025-11-13

Q2 2026 Earnings Release

2025-11-12

Q3 2025 Earnings Release

2025-11-12

Q3 2025 Earnings Release

2025-11-10

Q3 2025 Earnings Release

2025-11-10

October 2025 Sales and Revenue Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. INCY Stock
  4. Calendar Incyte Corporation